% alzhub.org library filter
% Source: https://alzhub.org/research?author=Tariot+PN&access=free
% 9 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{egan2019-30970186,
  author  = {Egan, M. F. and Kost, J. and Voss, T. and Mukai, Y. and Aisen, P. S. and Cummings, J. L. and Tariot, P. N. and Vellas, B. and others},
  title   = {{Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2019},
  doi     = {10.1056/nejmoa1812840},
  pmid    = {30970186},
  url     = {https://doi.org/10.1056/nejmoa1812840}
}

@article{egan2018-29719179,
  author  = {Egan, M. F. and Kost, J. and Tariot, P. N. and Aisen, P. S. and Cummings, J. L. and Vellas, B. and Sur, C. and Mukai, Y. and others},
  title   = {{Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1706441},
  pmid    = {29719179},
  url     = {https://doi.org/10.1056/nejmoa1706441}
}

@article{wessels2020-31764959,
  author  = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others},
  title   = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3988},
  pmid    = {31764959},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3988}
}

@article{atri2018-29318278,
  author  = {Atri, A. and Frölich, L. and Ballard, C. and Tariot, P. N. and Molinuevo, J. L. and Boneva, N. and Windfeld, K. and Raket, L. L. and others},
  title   = {{Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials}},
  journal = {JAMA},
  year    = {2018},
  doi     = {10.1001/jama.2017.20373},
  pmid    = {29318278},
  url     = {https://doi.org/10.1001/jama.2017.20373}
}

@article{tariot2011-21810649,
  author  = {Tariot, P. N. and Schneider, L. S. and Cummings, J. and Thomas, R. G. and Raman, R. and Jakimovich, L. J. and Loy, R. and Bartocci, B. and others},
  title   = {{Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease}},
  journal = {Archives of general psychiatry},
  year    = {2011},
  doi     = {10.1001/archgenpsychiatry.2011.72},
  pmid    = {21810649},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2011.72}
}

@article{salloway2011-21917766,
  author  = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others},
  title   = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e3182309fa5},
  pmid    = {21917766},
  url     = {https://doi.org/10.1212/wnl.0b013e3182309fa5}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{langbaum2013-23752908,
  author  = {Langbaum, J. B. and Fleisher, A. S. and Chen, K. and Ayutyanont, N. and Lopera, F. and Quiroz, Y. T. and Caselli, R. J. and Tariot, P. N. and others},
  title   = {{Ushering in the study and treatment of preclinical Alzheimer disease}},
  journal = {Nature reviews. Neurology},
  year    = {2013},
  doi     = {10.1038/nrneurol.2013.107},
  pmid    = {23752908},
  url     = {https://doi.org/10.1038/nrneurol.2013.107}
}

@article{raman2009-19571733,
  author  = {Raman, R. and Thomas, R. G. and Weiner, M. W. and Jack, C. R. and Ernstrom, K. and Aisen, P. S. and Tariot, P. N. and Quinn, J. F.},
  title   = {{MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2009},
  doi     = {10.1097/wad.0b013e3181aba588},
  pmid    = {19571733},
  url     = {https://doi.org/10.1097/wad.0b013e3181aba588}
}